Professor, Medicine - Nephrology, Stanford University Medical Center
Nephrology
Dr. Timothy Meyer, MD
|
|
Give Review
Dr. Timothy Meyer practices Nephrology. He went to medical school at Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School has a rank of 1 in research and a 12 in primary care Timothy Meyer is a published doctor. He published 44 publications, including: 'p53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress.' Timothy Meyer accepts Medicare payments and is registered with Medicare.gov.
Publications
- p53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress.
- Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.
- Approaches to Uremia.
- Prominent Accumulation in Hemodialysis Patients of Solutes Normally Cleared by Tubular Secretion.
- Numerous protein-bound solutes are cleared by the Kidney with high efficiency.
- A Zebrafish Model for Uremic Toxicity: Role of the Complement Pathway.
- The Effect of Left Ventricular Electrical Delay on AV Optimization for Cardiac Resynchronization Therapy.
- Searching for uremic toxins.
- Potential mechanisms underlying the effect of gender on response to cardiac resynchronization therapy: insights from the SMART-AV multicenter trial.
- Contribution of residual function to removal of protein-bound solutes in hemodialysis.
- Indoxyl sulfate: long suspected but not yet proven guilty.
- Anemia therapy in ESRD: time to move on.
- Influence of genetic background on albuminuria and Kidney injury in Ins2(+/C96Y) (Akita) mice.
- p-Cresol sulfate: further understanding of its cardiovascular Disease potential in CKD.
- Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial.
- Coated carbon hemoperfusion provides limited clearance of protein-bound solutes.
- Relationship of impaired olfactory function in ESRD to malnutrition and retained uremic molecules.
- Uremia.
- Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.
- Gene-expression profiles and age of donor Kidney biopsies obtained before transplantation distinguish medium term graft function.
- Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate.
- More work to do on renin-angiotensin system blockade.
- Impact of genetic background on nephropathy in diabetic mice.
- Transcriptional response in the unaffected Kidney after contralateral hydronephrosis or nephrectomy.
- Removal of P-cresol sulfate by hemodialysis.
- The clearance of protein-bound solutes by hemofiltration and hemodiafiltration.
- Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutes.
- Genome-wide gene-expression patterns of donor Kidney biopsies distinguish primary allograft function.
- Tubular injury in glomerular Disease.
- Immunosuppression for diabetic glomerular Disease?
- Renal structural abnormalities following recovery from acute puromycin nephrosis.
- Effects of antiHypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
- Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study.
- Ventilatory inefficiency in major depressive disorder: a potential adjunct for cardiac risk stratification in depressive disorders?
- Predictors of early mortality in implantable cardioverter-defibrillator recipients.
- Dialysis cannot be dosed.
- Reliability of t7-based mRNA linear amplification validated by gene expression analysis of human Kidney cells using cDNA microarrays.
- Alterations in gene expression in cadaveric vs. live donor Kidneys suggest impaired tubular counterbalance of oxidative stress at implantation.
- The removal of protein-bound solutes by dialysis.
- Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid c...
- Methylamine clearance by haemodialysis is low.
- New insights into uremic toxicity.
- Colonic contribution to uremic solutes.
Schools
Harvard Medical School
Conditions Treated
- Chronic Kidney Diseases
- Hypertension
- Hypertensive Heart and Chronic Kidney Disease
- Proteinuria
Doctors Specialties
- Nephrology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
Stanford University -
Harvard Medical School
Hospital
-
VA Palo Alto Health Care System
Helpful Reviews
Similar Doctors
|
|
Dr. Julie M. Yabu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rohini Arramreddy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tara I. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John D. Scandling Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Lafayette, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan Segal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Colin Lenihan, MD |
|
|
Dr. Ralph Rabkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sumi Sukumaran Nair, MD |